Forest Labs to pay $313 million in DOJ settlement
Medical Marketing & Media
September 16, 2010
Chronicling Nolan Auerbach’s latest $300 million+ settlement with a pharmaceutical company, Medical Marketing & Media inquired about the key differences between this case and the firm’s other successful pharmaceutical fraud cases. “Unlike other cases involving off-label marketing of drugs,” this case dealt with “illegally marketing a drug that has never been approved,” explained Nolan Auerbach managing partner Marcella Auerbach.